Overview

A Clinical Trials of Quick-Acting Heart Reliever for Moderate Coronary Stenosis

Status:
Completed
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
This study investigates the effective power of angina pectoris after Quick-Acting Heart Reliever and isosorbide dinitrate interventing respectively the patients with moderate coronary stenosis for six months. At the same time, the studying will assess the plaque, myocardial blood-supplying,quality of life and observe the end point of the heart (including the myocardial revascularization, death and myocardial infarction). The purpose is to study the function of the blood-quickening stasis-transforming formula Quick-Acting Heart Reliever for moderate coronary stenosis lesions.
Phase:
Phase 4
Details
Lead Sponsor:
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Treatments:
Aspirin
Isosorbide
Isosorbide Dinitrate
Isosorbide-5-mononitrate